Safety-net providers once often overcharged for medications covered under the federal cost-saving program have a new resource to protect against it.
The Health Resources & Services Administration (HRSA) has launched a new secure website intended to serve as a tool through which safety-net healthcare providers participating in the 340B federal drug pricing program can determine the maximum prices pharmaceutical companies can charge them for medications sold to them under the program, Administration officials announced this week.
In 2010, HRSA noted in a press release, Congress mandated that the government calculate and list such “ceiling prices” following reports by the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) that documented a pattern of overcharges. That legislation also created civil monetary penalties for drug manufacturers that “knowingly and intentionally” overcharge safety-net hospitals for 340B drugs.
The penalties took effect in January 2019.
“Today marks a positive milestone in the history of the 340B drug pricing program,” 340B Health President and CEO Maureen Testoni said in a statement. “Today’s launch of a secure website listing the maximum allowable prices for all 340B covered drugs brings a healthy dose of sunshine into a marketplace that has, for far too long, been a black box. Until today, hospitals, clinics, and health centers participating in 340B had no way to be sure they were paying the correct amount for the drugs they purchase.”
Testoni will be the featured guest on today’s edition of Monitor Mondays, the weekly healthcare news web broadcast produced by RACmonitor.
Annual spending in the 340B program has reportedly approached $20 billion during recent years, or approximately triple the rate of a decade ago. That sum represents a little more than 5 percent of all domestic drug sales.
In the past, Testoni noted, those payments undoubtedly amounted to considerably more than was allowable under the program.
“The Department of Health and Human Services (HHS) Office of Inspector General (OIG) has documented numerous instances of drug manufacturers overcharging safety-net providers for lifesaving medicines through 340B, undercutting resources designed to provide care to patients in need,” she said. “This overcharging led Congress to direct the Health Resources & Services Administration (HRSA) to create (this) secure website, where the agency can post the 340B ceiling price for every drug sold to those providers. It has taken nine years to see that law turned into action, but we are pleased to see it happen.”
“Starting today,” Testoni added, “authorized personnel working for 340B providers can check the HRSA website and ascertain whether they are being charged the correct amounts. With this new transparency comes a needed increase in accountability for drug manufacturers. When this information is combined with the civil monetary penalty authority that Congress granted HRSA, manufacturers that knowingly and intentionally charge safety-net providers too much will be subject to financial penalties.”
Testoni singled out HRSA’s Office of Pharmacy Affairs and its leader, Captain Krista Pedley, for making it all possible.
For more information about the 340B program, including access to periodic updates and a series of FAQs, go online to https://www.hrsa.gov/opa/index.html.
Programming Note:
Listen to Maureen Testoni report this story live during today’s Monitor Monday, 10-10:30 a.m. EST.
In December 2024, the U.S. Supreme Court declined to hear an appeal challenging an Arkansas law requiring pharmaceutical companies to provide drug discounts through third-party
There have been important developments in recent weeks on the 340B drug pricing program. Those who are familiar with 340B will know that it works
Please log in to your account to comment on this article.
Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!
Uncover critical guidance. Kay Piper provides an interactive review on coding guidelines and more in the AHA’s fourth quarter 2025 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance. Kay Piper provides an interactive review on coding guidelines and more in the AHA’s third quarter 2025 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance. Kay Piper provides an interactive review on coding guidelines and more in the AHA’s second quarter 2025 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Struggling with CMS’s 3-Day Payment Window? Join compliance expert Michael G. Calahan, PA, MBA, CCO, to master billing restrictions for pre-admission and inter-facility services. Learn how to avoid audit risks, optimize revenue cycle workflows, and ensure compliance across departments. Critical for C-suite leaders, providers, coders, revenue cycle teams, and compliance teams—this webcast delivers actionable strategies to protect reimbursements and meet federal regulations.
Providers face increasing Medicare audits when using skin substitute grafts, leaving many unprepared for claim denials and financial liabilities. Join veteran healthcare attorney Andrew B. Wachler, Esq., in this essential webcast and master the Medicare audit process, learn best practices for compliant billing and documentation, and mitigate fraud and abuse risks. With actionable insights and a live Q&A session, you’ll gain the tools to defend your practice and ensure compliance in this rapidly evolving landscape.
Dr. Ronald Hirsch dives into the basics of Medicare for clinicians to be successful as utilization review professionals. He’ll break down what Medicare does and doesn’t pay for, what services it provides and how hospitals get paid for providing those services – including both inpatient and outpatient. Learn how claims are prepared and how much patients must pay for their care. By attending our webcast, you will gain a new understanding of these issues and be better equipped to talk to patients, to their medical staff, and to their administrative team.
Hospitals face growing challenges in measuring observation metrics due to inconsistencies in classification, payer policies, and benchmarking practices. Join Tiffany Ferguson, LMSW, CMAC, ACM, and Anuja Mohla, DO, FACP, MBA, ACPA-C, CHCQM-PHYADV as they provide critical insights into refining observation metrics. This webcast will address key issues affecting observation data integrity and offer strategies for improving consistency in reporting. You will learn how to define meaningful metrics, clarify commonly misinterpreted terms, and apply best practices for benchmarking, and gain actionable strategies to enhance observation data reliability, mitigate financial risk, and drive better decision-making.
Copyright © 2025 RACmonitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
